About Waldenstrom Macroglobulinemia
Waldenstrom macroglobulinemia (WM) is a rare form of blood cancer. It is also called lymphoplasmacytic lymphoma. It is a type of non-Hodgkin lymphoma. It is characterized by the abnormal growth of a type of white blood cell called lymphoplasmacytic cells in the bone marrow. These abnormal cells displace healthy blood cells, leading to lower production of new healthy blood cells. People with WM have high levels of a specific antibody called immunoglobulin M (IgM) in their blood, which can make the blood thick and cause problems.
WM primarily affects older adults and is usually found in the bone marrow, although it can also involve the lymph nodes and spleen. Common symptoms of WM include anemia, weakness, loss of appetite, weight loss, peripheral neuropathy, fever, Raynaud's phenomenon, and changes in mental status. Hyperviscosity of the blood may cause nosebleeds, headaches, dizziness, and vision problems. The exact cause of WM is unknown, but both genetic and environmental factors may play a role. While there is no cure for WM, there are treatments available to manage its symptoms and improve quality of life.
WM is caused by genetic mutations (changes) in the DNA of certain white blood cells; however the exact of these mutations are still unknown. Several factors may be related to its development. These factors can be categorized into non-modifiable and modifiable risk factors. A person cannot change or control non-modifiable risk factors. Modifiable risk factors potentially can be changed or controlled to reduce the risk of developing a disease or condition.
Non-modifiable risk factors for WM include:
- Genetic factors: A mutation of the gene MYD88 is found in about 90 percent of people with WM. This genetic mutation may play a role in the development of the disease.
- Age: WM typically affects older adults, with a median age at diagnosis of 63-75 years.
- Sex Assigned at Birth: WM is more likely to develop in males compared to females.
- Race: People who are white are more likely to develop WM compared to other races.
- Family History: People who have a blood relative with WM or other types of lymphoma have a higher risk of developing WM.
Modifiable risk factors for WM include:
- Having hepatitis C or Acquired Immunodeficiency Syndrome (AIDS)
- Environmental factors: Exposure to certain substances in leather, rubber, solvents, dyes, paints and pesticides.
It's important to note that these risk factors do not guarantee the development of WM, and having one or more of these risk factors does not mean that someone will definitely develop the disease. The exact interplay between these risk factors and the development of WM is still being studied by researchers.
Overall, while there are some identified risk factors for WM, it is important to remember that the exact causes of the disease are still not fully understood. Ongoing research aims to further unravel the complex relationship between genetic, environmental, and viral factors in the development of Waldenstrom Macroglobulinemia.
WM is a slow-growing cancer. Symptoms often come on gradually. Some people with WM do not have any symptoms and learn of the condition during other healthcare.
The most common symptoms of WM are weakness and extreme tiredness (fatigue) due to a shortage of red blood cells, which is called anemia. Other symptoms may include:
- Fever
- Night sweats
- Loss of appetite
- Unintended weight loss
- Tingling or change in sensation in fingers and toes (peripheral neuropathy). This occurs when the IgM protein attaches to the protective covering of nerve cells and breaks it down, leading to damaged nerves that cannot carry signals normally.
As WM progresses, there are additional symptoms that may occur. These symptoms are related to the accumulation of lymphoplasmacytic cells in different tissues and the hyperviscoscity of blood. Symptoms include:
- Nosebleeds
- Bleeding gums
- Blurred vision or vision loss
- Headaches
- Enlarged liver (hepatomegaly)
- Enlarged spleen (splenomegaly)
- Enlarged lymph nodes (lymphadenopathy)
- Difficulty fighting off infections due to a lack of normal white blood cells
It's important to note that some individuals with WM may not experience any symptoms for several years after diagnosis. As the disease progresses, it can affect organs and lead to more severe symptoms.
When diagnosing WM, healthcare providers may use a combination of examinations, tests, and procedures to gather information and make an accurate diagnosis. These may include:
- Medical history: The doctor will ask about the patient's medical history to gather relevant information
- Physical Exam: During a physical exam, the healthcare provider will look for physical signs of a medical problem, such as pain, swelling, or the presence of masses within the body.
- Blood Tests: Blood samples may be obtained to measure levels of certain proteins and cells in the blood. These tests can help identify abnormalities that may be associated with WM.
- Urine Tests: A urine sample may be obtained to check of IgM, a sign of WM
- Biopsy: A tissue sample, usually from a lymph node, is taken and analyzed in a laboratory to confirm the diagnosis.
- Imaging Studies: CT scan, PET scan, or MRI scan can help identify the location and extent of lymphoma in the body. These images can help detect any abnormalities or signs of WM.
- Bone marrow aspiration and biopsy: Small amounts of bone marrow and bone are removed using a needle for examination under a microscope.
- Chromosome tests: Molecular cytogenetics, FISH, and PCR tests can check for genetic abnormalities that aid in identifying the type of lymphoma and planning treatment.
To determine the stage or severity of WM, additional examinations, tests, and procedures may be conducted. These can help healthcare providers understand how advanced the disease is and guide treatment decisions. Some examples include:
- Multiparametric Flow Cytometry: This procedure uses specialized techniques to analyze cells in the blood or bone marrow. It can help identify abnormal cells associated with WM.
- Fluorescence In Situ Hybridization (FISH) and Molecular Tests: FISH is a laboratory technique that can detect genetic abnormalities in cells. Molecular tests involve analyzing specific genes or DNA sequences to identify mutations or changes that may be related to WM.
It's important to review the results of examinations, tests and procedures with your doctor. The doctor can explain the interpretation of tests and provide a diagnosis.
If you experience any changes or worsening of symptoms after your physical exam or diagnostic procedures, it's crucial to follow up with your healthcare provider for further evaluation and guidance.
The goals of treatment for WM are to relieve symptoms, slow disease progression, prevent organ damage, and maintain quality of life. There are several types of medications, therapies, therapeutic procedures, and other treatments that can help achieve these goals:
If a person with WM has no symptoms, doctors may choose to closely monitor them with regular tests instead of starting immediate treatment.
Medications:
- Chemotherapy: High dose chemotherapy is often used as the first-line treatment for WM. Chemotherapy kills cancer and helps control their growth. It helps clear out the existing bone marrow and reduce the number of cancer cells.
- Targeted Drug Therapy: Targeted drugs attack specific parts of cancer cells to disrupt the functions needed for the cancer cell to grow, mulitply, or spread. An example of targeted rug therapy are Brutons tyrosine kinase (BTK) inhibitors.
- Immune-Modulating Drugs: These drugs help modulate the immune system to fight against cancer cells. They can be used as part of the treatment plan for WM.
Therapeutic Procedures:
- Plasmapheresis: This is a therapeutic procedure where the IgM antibody (a type of protein produced by cancer cells) is removed from the blood. It can be effective for some patients with WM.
- Plasma Exchange: Similar to plasmapheresis, plasma exchange involves removing and replacing a portion of the blood plasma. This procedure helps reduce the levels of abnormal proteins in the blood.
- Radiation therapy: Uses high-energy radiation to kill cancer cells.
- Stem Cell Transplantation: In rare cases, younger adults with WM who have not responded to other treatments may undergo a stem cell transplant. This procedure involves replacing damaged bone marrow with healthy stem cells to promote the growth of healthy blood cells.
- Spleen Removal (Splenectomy): If WM is causing a painful and swollen spleen that does not respond to medication, removing the spleen may be recommended. However, this is not a common treatment for WM.
Supportive Care: Other treatments may be recommended to manage symptoms and providing necessary care to improve quality of life for individuals with WM.
It's important for individuals with WM to discuss their specific treatment options with their healthcare team. The choice of treatment depends on factors such as age, overall health, disease characteristics, and individual preferences. By working closely with their healthcare team, individuals can make informed decisions about the best treatment plan for their condition.
The natural progression of WM varies from person to person. Some individuals may experience no symptoms for several years after diagnosis, while others may have symptoms earlier on. Early symptoms often include fatigue, low energy due to anemia (low red blood cell count), tingling in fingers and toes, and bleeding in the nose and gums.
As WM progresses, it can affect various organs in the body. The liver, spleen, and lymph nodes may become swollen. The hyperviscosity caused by the excessive IgM can lead to blurred vision or problems with blood flow to the retina.
Additional complications associated with Waldenstrom Macroglobulinemia include:
- Amyloidosis: In this condition, abnormal proteins build up in organs such as the heart, lungs, and kidneys.
- Cryoglobulinemia: This complication causes blood proteins to clump in hands and feet as a reaction to cold. This causes pain and turns the hands and feet blue or white.
- Hyperviscosity syndrome: Thickening of the blood due to high levels of IgM can lead to complications such as stroke and organ damage.
- Cytopenias: WM can cause a decrease in the number of red blood cells, white blood cells, and platelets in the bloodstream. This can result in anemia, increased risk of infections, and easy bleeding or bruising.
- Organ damage: As WM progresses, it can affect various organs like the liver, spleen, and lymph nodes. This can lead to swelling and impair their normal function.
While there is currently no cure for WM, there are treatment options available to manage symptoms, slow disease progression, and reduce complications. The specific treatment approach will depend on individual factors such as overall health and disease stage.
It's important to note that treatment decisions should be made in consultation with a healthcare professional specializing in WM. They will consider individual factors and tailor a treatment plan that best suits each person's needs.